Search clinical trials for: Programmed Cell Death, Type II

Total 10000 results

Wei Zhou

Active, not recruiting

Phase II Clinical Study of Adebrelimab Combined with Apatinib in the Treatment of Locally Advanced Non-small Cell Lung Cancer Patients with Radiation Pneumonitis

Unresectable Locally Advanced Non-small Cell Lung Cancer

China
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Camrelizumab Combined With Apatinib Mesylate or Camrelizumab Alone for First-line Treatment in Subjects With Programmed Death Ligand 1 (PD-L1) Positive Relapsed or Advanced Non-small Cell Lung Cancer (NSCLC)

PD-L1 Positive Non-small Cell Lung Cancer
Sun Yat-sen University
Eli Lilly and Company; Ministry of Health, China; Amylin Pharmaceuticals, LLC.

Completed

Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients

Diabetes Mellitus, Type 2 | Newly Diagnosed

China
Evopoint Biosciences Inc.

Recruiting

Clinical Study of XNW5004 Combined With CHOP/CHOEP in the Treatment of Untreated Peripheral T-Cell Lymphoma

Peripheral T-cell Lymphoma | Non-hodgkin Lymphoma

China
Sun Yat-sen University

Not yet recruiting

Sacituzumab Tirumotecan (Sac-TMT/SKB264) Plus Tagitanlimab (KL-A167) in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma and Gastric/Gastroesophageal Junction Adenocarcinoma

Gastric Adenocarcinoma | Esophageal Squamous Cell Carcinoma (ESCC) | Gastroesophageal Junction Adenocarcinoma | ESCC | GC/GEJC

China

This is a preview

Log in or create a free account to see all matching trials and use the full search.

Log in Register

Subscribe